Career history of Greg F. Walker
Former positions of Greg F. Walker
| Companies | Position | Start | End |
|---|---|---|---|
| Ludwig-Maximilians-Universität München | Corporate Officer/Principal | 2005-12-31 | 2005-12-31 |
| University of Vienna | Corporate Officer/Principal | 1999-12-31 | 2001-12-31 |
Haemostatix Ltd.
 Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Corporate Officer/Principal | - | - |
Training of Greg F. Walker
| University of Otago | Doctorate Degree |
Statistics
International
| United Kingdom | 2 |
| New Zealand | 2 |
| Austria | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Haemostatix Ltd.
Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Greg F. Walker
- Experience
